Biotechnology and medical technology companies looking to Europe have almost 28 different markets to choose from. While many companies look to key destinations such as Germany, France and the UK, there is an emerging trend to target smaller markets such as Scandinavia and Switzerland, for initial EU market entry.
This BioBreakfast session will feature companies discussing their market strategies and risk management approaches to the EU.
Date: Tuesday 21st March 2017
Time: Registration from 7:15am for a 7.30am networking breakfast followed by presentations and discussion from 8.00am – 9:00am
Venue: The Cube, ACMI, Federation Square, Melbourne
John Sharman, Chief Executive Officer, Medical Developments International
Jefferson Harcourt, Director, Grey Innovation
Additional speaker tbc
(Prices include GST)
To check if your organisation is a member, click here
Full refund given up to 7 days prior to the event
No refunds within 7 days of the event